Wang et al. recently reported that the differences in RKIP protein levels were statistically significant between patients with early-stage (TNM I/II) versus late-stage (stage III/IV) NSCLC [43] with reduced RKIP expression levels in patients with late-stage NSCLC. Here, PEBP1 is linked to non-small cell lung carcinoma.